AG
ADVM

Algert Global’s Adverum Biotechnologies ADVM Stock Holding History

Algert Global’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,669
Closed -$140K – 1160
2022
Q2 		$140K Sell
11,669
-13,798
-54% -$145K 0.01% 1074
2022
Q1 		$334K Buy
25,467
+9,222
+57% +$135K 0.02% 939
2021
Q4 		$286K Sell
16,245
-6,904
-30% -$138K 0.04% 745
2021
Q3 		$502K Buy
23,149
+14,934
+182% +$381K 0.07% 536
2021
Q2 		$288K Buy
8,215
+1,005
+14% +$54.1K 0.1% 294
2021
Q1 		$711K Sell
7,210
-5,556
-44% -$667K 0.23% 158
2020
Q4 		$1.38M Buy
12,766
+3,679
+40% +$455K 0.39% 84
2020
Q3 		$936K Buy
9,087
+6,094
+204% +$913K 0.3% 135
2020
Q2 		$625K Hold
2,993
– – 0.21% 155
2020
Q1 		$292K Buy
+2,993
New +$349K 0.12% 253
2019
Q3 		– Sell
-2,536
Closed -$302K – 360
2019
Q2 		$302K Buy
+2,536
New +$210K 0.11% 224
2019
Q1 		– Sell
-9,411
Closed -$296K – 300
2018
Q4 		$296K Buy
9,411
+1,465
+18% +$59.6K 0.08% 284
2018
Q3 		$481K Sell
7,946
-285
-3% -$16K 0.1% 252
2018
Q2 		$436K Buy
8,231
+933
+13% +$56.1K 0.09% 253
2018
Q1 		$423K Buy
+7,298
New +$454K 0.08% 266

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Algert Global's ADVM Position: Q3 2022 in Review

Algert Global sold out of Adverum Biotechnologies (ADVM) in Q3 2022, closing a stake of 11,669 shares — an estimated $140K sold.

Algert Global first reported a position in ADVM in Q1 2018 and held it in 15 quarters. The position peaked at $1.38M in Q4 2020. 78 funds tracked by Wall St. Rank hold ADVM as of Q3 2022.

  • Algert Global reported no remaining Adverum Biotechnologies position as of Q3 2022 after selling out during the quarter.
  • Algert Global sold 11,669 Adverum Biotechnologies shares in Q3 2022, an estimated $140K.
  • Algert Global first reported a position in Adverum Biotechnologies in Q1 2018 and held it in 15 quarters.
  • Algert Global's Adverum Biotechnologies position peaked at $1.38M in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2022.

Based on Algert Global's 13F filing for Q3 2022, filed 15 Nov 2022.